Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Island Pharmaceuticals Ltd has announced the retirement of key board members Dr. Paul MacLeman and Dr. Anna Lavelle following their 2024 Annual General Meeting. Both executives have played pivotal roles in the company’s strategic progress and clinical achievements. The company plans to appoint a new Chair soon, marking a significant transition as it continues its focus on antiviral drug development.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.